Fmoc-2-Fluoro-L-Phenylalanine is an Fmoc-protected amino acid derivative bearing a fluorine substituent at the 2-position of the phenylalanine side chain and an L-configuration at the alpha carbon. The molecule contains a carboxylic acid functionality and a primary amine masked as an Fmoc carbamate, while the ortho-fluoro aryl group provides a distinct electron-withdrawing and steric influence relative to unmodified phenylalanine. In peptide chemistry, the Fmoc-protected form is used as a building block for stepwise incorporation into peptide chains via protected-amino-acid coupling strategies, and the fluorinated aromatic handle supports structure-activity studies, conformational probing, and analytical method development for fluorinated peptide analogues.
CAT No: CP14406
CAS No:205526-26-7
Synonyms/Alias:205526-26-7;Fmoc-Phe(2-F)-OH;Fmoc-2-fluoro-L-phenylalanine;FMOC-L-2-Fluorophe;Fmoc-L-2-Fluorophenylalanine;fmoc-2-fluoro-l-phe;Fmoc-L-phe(2-F)-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)propanoicacid;fmoc-l-2-fluoro-phe-oh;(s)-n-fmoc-2-fluorophenylalanine;2-fluoro-l-phenylalanine,n-fmocprotected;ST50826335;n-alpha-(9-fluorenylmethyloxycarbonyl)-l-2-fluoro-phenylalanine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(2-fluorophenyl)propanoicacid;(s)-2-(((9h-fluoren-9-yl)methoxy)carbonylamino)-3-(2-fluorophenyl)propanoicacid;(s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(2-fluoro-phenyl)-propionicacid;FMOC-D-2-FLUOROPHENYLALANINE;(2S)-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)-3-(2-FLUOROPHENYL)PROPANOICACID;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(2-fluorophenyl)propanoicacid;AC1MC1CX;47769_ALDRICH;SCHEMBL119590;FMOC-O-FLUORO-L-PHE-OH;Jsp004213;47769_FLUKA
Fmoc-2-Fluoro-L-Phenylalanine is an Fmoc-protected L-phenylalanine analog in which the alpha position bears a fluorine substituent, creating a chiral, fluorinated amino acid building block for peptide chemistry. The molecule contains the Fmoc carbamate on the amino group and a carboxylic acid functionality suitable for amide bond formation after activation, while the 2-fluoro stereocenter can influence coupling outcomes, conformational preferences, and metabolic stability of resulting peptides or peptidomimetics. The side chain remains a stereochemically consistent benzyl group, enabling direct incorporation into aromatic-rich sequences and downstream functionalization strategies that preserve the fluorinated alpha-carbon motif. The presence of a C-F bond and the protected amine support controlled synthetic handling, including standard Fmoc deprotection workflows and subsequent derivatization of the peptide backbone or side-chain environment.
1. Peptide Synthesis
Fmoc-2-Fluoro-L-Phenylalanine is applied in solid-phase peptide synthesis and related peptide building workflows where an Fmoc-protected amino acid with an activated carboxyl group is required for reliable peptide coupling. The Fmoc carbamate enables orthogonal deprotection under base conditions to expose the amino functionality for sequential chain elongation, while the fluorinated alpha-carbon provides a stereodefined residue that can be retained through coupling and deprotection steps. The combination of an aromatic benzyl side chain and the 2-fluoro substitution supports incorporation into peptides used for receptor-binding studies, protease resistance profiling, and backbone-modified analog libraries. Fluorinated phenylalanine residues can be used to generate peptide standards and structure-defined analogs for downstream analytical characterization and method development in peptide science.
2. Peptidomimetics And SAR
Fmoc-2-Fluoro-L-Phenylalanine supports peptidomimetic construction and structure-activity relationship studies by introducing a fluorinated stereocenter at the amino acid alpha position while maintaining the phenylalanine aromatic side chain. The C-F bond and the defined L-configuration can modulate local polarity, conformational bias, and hydrogen-bonding patterns in the resulting amide-containing scaffold, enabling SAR-oriented comparison against non-fluorinated phenylalanine analogs. The Fmoc-protected architecture allows rapid substitution into peptide-like backbones, facilitating systematic library synthesis for fragment-to-lead optimization and backbone engineering. Downstream use includes preparing fluorinated peptide analogs for binding assays, stability screening, and mechanistic studies where backbone stereochemistry and fluorine placement are key variables.
3. Chemical Biology Labeling
Fmoc-2-Fluoro-L-Phenylalanine is utilized in chemical biology workflows that require site-defined incorporation of a fluorinated amino acid residue into peptides or protein fragments for labeling and molecular recognition studies. The protected amine and carboxylic acid enable standard peptide coupling chemistry, allowing the fluorinated residue to be positioned at specific sequence locations that can serve as a spectroscopic handle or a chemically stable motif. The aromatic side chain can participate in hydrophobic interactions and can be used to tune local microenvironments in conjugates, while the alpha-fluoro stereocenter can influence reactivity and stability of the labeled biomolecule. The resulting fluorinated peptides can be employed as analytical references, binding probes, or substrates in biochemical investigations that depend on defined backbone composition.
4. Process Chemistry Intermediate
Fmoc-2-Fluoro-L-Phenylalanine serves as a chiral amino acid intermediate for process chemistry and fine chemical synthesis where Fmoc-protected building blocks are manufactured and then converted into larger peptide or peptidomimetic products. The Fmoc carbamate provides a robust protection strategy for the amino functionality during handling, while the fluorinated alpha-carbon remains intact through typical activation and coupling sequences, supporting reproducible downstream transformations. The molecule's defined stereochemistry and single fluorine substituent make it suitable for controlled route design in which the fluorinated residue must be introduced at a specific stage of synthesis. The compound can be applied to manufacturing of fluorinated peptide reagents, research-grade analogs, and intermediate streams that feed into multi-step peptide assembly operations.
5. Analytical Standards
Fmoc-2-Fluoro-L-Phenylalanine is suitable for analytical research and method development where fluorinated amino acid and peptide standards are needed for chromatographic, mass spectrometric, and structural verification. The Fmoc-protected form enables incorporation into defined peptide sequences that can be used to generate reference materials for LC-MS/MS fragmentation behavior and retention-time mapping of fluorinated phenylalanine residues. The presence of both an aromatic side chain and a fluorinated alpha position supports unambiguous detection patterns that help distinguish fluorinated analogs from non-fluorinated counterparts. The compound can therefore be employed to prepare sequence-defined calibration tools, impurity reference sets, and characterization peptides used in quality evaluation of peptide synthesis workflows and downstream product development.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.